R&D
Female scientist in the lab

Clinical research demands agile CROs

An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.

Sales & Marketing
12 questions with Dermot Kenny
Sponsored

12 Questions with Dermot Kenny

Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.

Market Access
British pound coins and two yellow and blue pills

Missing metrics on the UK’s VPAG

It's hard to take stock of what’s happening operationally with the UK's main pricing scheme, VPAG, given the absence of reporting by the DHSC.

Sales & Marketing

Sales & Marketing
12 questions with Dermot Kenny
Sponsored

12 Questions with Dermot Kenny

Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.

Digital

Market Access

Editor's Picks

  1. AC Immune says Parkinson's drug slows progression
  2. UK confirms lower clawback rate for NHS medicines
  3. Antibiotic is first approval in FDA national priority scheme
  4. Agreement reached on EU's new pharma legislation
  5. UK teams up with Singapore on healthtech regulation

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

R&D
Female scientist in the lab

Clinical research demands agile CROs

An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.

more